35Pharma Closes Series C Financing to Advance Clinical Pipeline of Activin Inhibitors for Pulmonary Hypertension, Cardiometabolic Disease and Obesity
November 26, 2024 08:00 ET
|
35Pharma Inc.
35Pharma Closes Series C Financing to Advance Clinical Pipeline of Activin Inhibitors for Pulmonary Hypertension, Cardiometabolic Disease and Obesity
Announcing Finix’s $75M Series C
October 24, 2024 09:00 ET
|
Finix
SAN FRANCISCO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Finix, the full-stack payment processor enabling businesses to accept and send payments online and in-store, today announced it has raised $75...
Simbe Raises $50 Million in Series C Funding Led by Growth Equity at Goldman Sachs Alternatives
October 24, 2024 06:00 ET
|
Simbe Robotics
SAN FRANCISCO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Simbe, a leading provider of Store Intelligence™ solutions, today announced the closing of a $50 million Series C equity financing round led by...
Oshi Health Raises $60M Series C to Strengthen Its Position as the Category Leader for Virtual Digestive Care
October 16, 2024 08:00 ET
|
Oshi Health
Oshi Health Raises $60M Series C to Strengthen Its Position as the Category Leader for Virtual Digestive Care
ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base
September 17, 2024 04:00 ET
|
AKAMPION
Existing investors and new investor Double Point Ventures join forces to support ImmunOs TherapeuticsInvestment secures funding of ongoing promising clinical trial of IOS-1002 in solid cancers ...
Tevogen Bio Secures $6 Million Series C Preferred Stock Investment
August 22, 2024 09:00 ET
|
Tevogen Bio Inc
WARREN, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...
HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration
July 10, 2024 03:00 ET
|
HepaRegeniX GmbH
Funds to support Phase Ib clinical trial of HRX-215 in the US and an international multicenter Phase IIa clinical trial in liver regenerationElias Papatheodorou moves from Chair of the Board to CEO of...
Alumis Announces Upsized $259M Series C Financing to Advance Clinical-stage Pipeline of Oral Therapies Designed to Address Immune Dysfunction
March 06, 2024 08:00 ET
|
Alumis Inc
– Financing led by Foresite Capital, Samsara BioCapital and venBio Partners with participation from additional new and existing investors – – Proceeds will support ongoing comprehensive mid to...
Yalo secures USD$20 million investment and strategic partnership to lead the AI-Driven commerce revolution
December 13, 2023 07:00 ET
|
Yalo
Yalo secures $20M from Glisco Partners for AI-driven commerce revolution, enhancing personalized marketing for 2.6M+ merchants in Latin America.
Redpanda Raises $100M in Series C Funding
June 27, 2023 08:00 ET
|
Redpanda Data
SAN FRANCISCO, June 27, 2023 (GLOBE NEWSWIRE) -- Redpanda Data announced today that it has raised $100M in Series C funding, led by returning investors Lightspeed Venture Partners, along with GV and...